TipRanks
Cocrystal Pharma Inc (DE:8CC)
FRANKFURT:8CC
Germany Market
8CC
Cocrystal Pharma
RESEARCH TOOLSreports

Cocrystal Pharma (8CC) Income Statement

0 Followers

Cocrystal Pharma Income Statement

Last quarter (Q2 2026), Cocrystal Pharma's total revenue was $105.00K, an increase of Infinity% from the same quarter last year. In Q2, Cocrystal Pharma's net income was $-3.16M. See Cocrystal Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.05M$ -12.54M$ -15.17M$ -12.39M$ -8.79M
Operating Expenses
$ 3.96M$ 5.34M$ 3.39M$ 26.44M$ 5.43M
Depreciation and Amortization
$ 376.00K$ 126.00K$ 189.00K$ 185.00K$ 190.00K
EBITDA
$ -8.46M$ -17.38M$ -20.97M$ -17.95M$ -13.99M
Operating Income
$ -9.02M$ -17.88M$ -18.56M$ -38.83M$ -14.22M
Other Income/Expenses
$ 188.00K$ 374.00K$ 575.00K$ -8.00K$ 36.00K
Pretax Income
$ -8.83M$ -17.50M$ -17.98M$ -38.84M$ -14.19M
Net Income
$ -8.83M$ -17.50M$ -17.98M$ -38.84M$ -14.19M
Per Share Metrics
Basic EPS
$ -0.78$ -1.72$ 0.00$ -4.77$ -1.85
Diluted EPS
$ -0.78$ -1.72$ 0.00$ -4.77$ -1.85
Weighted Average Shares Outstanding
 11.29M 10.17M 9.65M 8.14M 7.69M
Weighted Average Shares Outstanding (Diluted)
 11.29M 10.17M 9.65M 8.14M 7.69M
Currency in USD

Cocrystal Pharma Earnings and Revenue History